Brief: Summit Is Considering A $15 Billion Partnership With AstraZeneca - Bloomberg News
July 3 (Reuters) - SUMMIT IS CONSIDERING A $15 BILLION PARTNERSHIP WITH ASTRAZENECA - BLOOMBERG NEWS Source text: [https://tinyurl.com/bdzjwy4y] Further company coverage: AZN.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Summit Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
Summit Therapeutics rebounds after pulling stock offering
Brief: Summit Therapeutics Withdraws Proposed Underwritten Public Offering Effective- SEC Filing
Summit Therapeutics falls on launching $500 mln stock offering